Pharma Pricing
-
5 Must-Knows Before Wednesday’s Stock Market Open
U.S. stocks are set for a muted open as geopolitical tensions surrounding President Trump’s Greenland stance and tariff threats pressure markets. Investors are wary of escalating trade disputes impacting global capital flows. Key developments include institutional reactions to U.S. debt, Trump’s World Economic Forum address, tech earnings like Netflix, AI partnerships with ServiceNow, and airline sector optimism, alongside pharma’s challenges with pricing and patent cliffs.
